• In Vitro Activity of Sisomicin vs. Other Aminoglycosides in

  2026-04-26

  This study by Stewart and Bodey rigorously compares the antibacterial activity of sisomicin—a new aminoglycoside at the time—with established agents such as gentamicin, tobramycin, and kanamycin. Their findings reveal sisomicin's enhanced potency against key gram-negative pathogens and delineate the scope and limitations of cross-resistance, informing antibiotic resistance research and guiding the selection of aminoglycoside antibiotics in microbiological workflows.

• G418 Sulfate (Geneticin): Selection and Antiviral Workflows

  2026-04-25

  G418 Sulfate (Geneticin) offers unmatched precision for genetic engineering and antiviral research, enabling robust selection of neomycin-resistant cells and potent inhibition of Dengue virus. This article translates cutting-edge methodology and troubleshooting into actionable protocols, empowering scientists to maximize reliability and efficiency with APExBIO’s ultra-pure G-418 Sulfate.

• AT13387: Redefining Hsp90 Inhibition in Translational Oncolo

  2026-04-24

  This thought-leadership article explores the mechanistic foundations, experimental best practices, and translational promise of AT13387 as a next-generation Hsp90 inhibitor for cancer biology research. By integrating the latest mechanistic insights and cross-linking to key literature, it offers strategic guidance for researchers seeking robust, reproducible data and highlights the critical role of apoptosis and cell cycle modulation in modern oncology workflows.

• GLT-1 Upregulation Mitigates TBI via CB1-CREB Pathway Inhibi

  2026-04-24

  This study uncovers that enhancing GLT-1 expression in astrocytes attenuates neuronal apoptosis and cognitive deficits after traumatic brain injury (TBI) by suppressing the CB1-CREB signaling axis. The findings highlight a mechanistic link between endocannabinoid signaling, astrocytic glutamate transport, and neuroprotection, suggesting new intervention targets for TBI.

• COX-2 Pathway Modulation in Muscle Ischemia Post-Venom Injur

  2026-04-23

  This study uncovers the temporal dual role of the cyclooxygenase-2 (COX-2) pathway in skeletal muscle recovery after Bothrops asper venom-induced injury. Early COX-2 inhibition worsens ischemia, but later enhances angiogenic signaling, offering new insight into the timing of selective COX-2 inhibitor use in tissue regeneration models.

• Gentamycin Sulfate in Advanced Bacterial Protein Synthesis R

  2026-04-23

  Gentamycin Sulfate empowers researchers to unravel mechanisms of antibiotic resistance and ribosome function in Gram-negative pathogens. This guide delivers actionable workflows, protocol refinements, and troubleshooting strategies inspired by the latest multidrug-resistance transmission studies.

• CX-5461 Induces DNA Damage and Mitotic Catastrophe in Cervic

  2026-04-22

  This study demonstrates that CX-5461, a selective RNA polymerase I inhibitor, suppresses cervical cancer cell growth by inducing DNA damage and mitotic catastrophe, and enhances cisplatin sensitivity. The findings highlight a mechanistically distinct pathway for targeting ribosome biogenesis in cervical cancer, offering new avenues for overcoming chemoresistance.

• Maternal Deltamethrin Exposure Induces p53-Mediated Ferropto

  2026-04-22

  This study reveals that prenatal and early postnatal exposure to deltamethrin impairs hippocampal learning and memory in male rat offspring via p53-mediated ferroptosis. The work elucidates a mechanistic pathway linking environmental neurotoxin exposure to iron-dependent neuronal death, offering a platform for further investigation into targeted neuroprotection.

• Hepatic sEH Modulates Osteoclastogenesis via Nrf2 in Osteopo

  2026-04-21

  This study uncovers a novel liver-bone regulatory axis in osteoporosis, demonstrating that hepatic soluble epoxide hydrolase (sEH) promotes osteoclastogenesis through suppression of the Nrf2 signaling pathway. By linking epoxyeicosatrienoic acids metabolism to redox imbalance and bone health, the paper provides mechanistic insight with translational potential for chronic inflammation research.

• HPF: Elevating hROS Sensing for Translational Phototherapy

  2026-04-21

  This thought-leadership article unpacks the mechanistic precision and translational importance of HPF (hydroxyphenyl fluorescein) for highly reactive oxygen species (hROS) detection in advanced phototherapy research. Leveraging new insights from multimodal cancer therapy, it bridges biological rationale, protocol optimization, and competitive positioning, offering strategic guidance for researchers seeking to map and modulate oxidative stress with confidence.

• Nintedanib (BIBF 1120): Protocols and Innovations for Cancer

  2026-04-20

  Nintedanib (BIBF 1120) is a triple angiokinase inhibitor that empowers researchers to dissect angiogenesis inhibition pathways in oncology and fibrotic disease studies. This guide translates high-impact findings and detailed workflows into actionable protocols, troubleshooting advice, and strategic insights for maximizing experimental reproducibility with APExBIO’s trusted supply.

• Bestatin (Ubenimex): Applied Workflows for Cancer and MDR Re

  2026-04-20

  Bestatin (Ubenimex) is a highly selective aminopeptidase inhibitor that empowers advanced cancer and multidrug resistance (MDR) research with unrivaled specificity. Learn how to optimize experimental design, troubleshoot common pitfalls, and leverage recent angiogenesis findings using APExBIO’s Bestatin for robust, reproducible results.

• Cholecystokinin Octapeptide Ammonium: Applied Protocols & In

  2026-04-19

  Cholecystokinin octapeptide ammonium (CCK-8 ammonium) enables targeted modulation of neuronal plasticity, immune responses, and cellular survival in advanced research assays. This article translates recent evidence and real-world workflows into actionable protocols, troubleshooting guidance, and comparative insights, highlighting how SKU C8717 from APExBIO delivers reproducibility for neurobiology and beyond.

• Crizotinib Hydrochloride: Optimizing ALK Kinase Inhibitor Wo

  2026-04-18

  Crizotinib hydrochloride unlocks precise inhibition of ALK, c-Met, and ROS1 in advanced gastric cancer assembloid models, enabling more physiologically relevant drug screening and mechanistic studies. With APExBIO's high-purity supply, researchers can confidently dissect oncogenic kinase signaling pathways and overcome resistance in complex tumor microenvironments.

• Gentamycin Sulfate in Multidrug Resistance: Mechanisms and I

  2026-04-17

  Explore the advanced mechanisms and practical implications of Gentamycin Sulfate, a potent aminoglycoside antibiotic, for unraveling bacterial protein synthesis and resistance dynamics. This article uniquely bridges recent genotypic findings with actionable guidance for next-generation research.

16746 records 1/1117 page Next 12345 下5页 Last page